The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains
- PMID: 10395874
- DOI: 10.1086/314905
The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains
Abstract
Wild type mumps viruses are highly neurotropic and a frequent cause of aseptic meningitis in unvaccinated humans. To test whether attenuated mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey neurovirulence safety test (MNVT) is performed. However, results with several mumps virus MNVTs have raised questions as to whether the test can reliably discriminate neurovirulent from nonneurovirulent mumps virus strains. Here, various mumps virus strains representing a wide range of neuropathogenicity were tested in a standardized MNVT. A trend of higher neurovirulence scores was observed in monkeys inoculated with wild type mumps virus versus vaccine strains, although differences were not statistically significant. Results indicated the need for further examination and refinement of the MNVT or for development of alternative MNVTs.
Similar articles
-
Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.Acta Virol. 1985 May;29(3):225-30. Acta Virol. 1985. PMID: 2864823
-
Monkey neurovirulence test for live mumps vaccine.Biologicals. 1996 Sep;24(3):223-4. doi: 10.1006/biol.1996.0030. Biologicals. 1996. PMID: 8978921 No abstract available.
-
The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.J Infect Dis. 2005 Apr 1;191(7):1123-8. doi: 10.1086/428098. Epub 2005 Feb 22. J Infect Dis. 2005. PMID: 15747248
-
Neurovirulence safety testing of mumps vaccines--historical perspective and current status.Vaccine. 2011 Apr 5;29(16):2850-5. doi: 10.1016/j.vaccine.2011.02.005. Epub 2011 Feb 18. Vaccine. 2011. PMID: 21334386 Review.
-
Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.Dev Biol Stand. 1993;78:61-70. Dev Biol Stand. 1993. PMID: 8388832 Review.
Cited by
-
High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence.Vaccine. 2010 Dec 6;28(52):8315-26. doi: 10.1016/j.vaccine.2010.07.070. Epub 2010 Aug 3. Vaccine. 2010. PMID: 20688036 Free PMC article.
-
Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.J Virol. 2015 Jun;89(12):6338-51. doi: 10.1128/JVI.00222-15. Epub 2015 Apr 8. J Virol. 2015. PMID: 25855732 Free PMC article.
-
Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate.J Virol. 2013 Jul;87(14):8158-68. doi: 10.1128/JVI.01028-13. Epub 2013 May 15. J Virol. 2013. PMID: 23678169 Free PMC article.
-
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.J Virol. 2014 Jun;88(12):6690-701. doi: 10.1128/JVI.03441-13. Epub 2014 Apr 2. J Virol. 2014. PMID: 24696472 Free PMC article.
-
Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.J Virol. 2011 Jul;85(14):7059-69. doi: 10.1128/JVI.00245-11. Epub 2011 May 4. J Virol. 2011. PMID: 21543475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources